Bhasin, N., M. Kumar Sharma, D. N. Yadav, and D. M. Kumar Kumawat. “Diabetes Ketoacidosis Is a Cause of Concern in Sodium-Glucose Co-Transporter-2 Inhibitors Medication: Pharmaceutical Science-Pharmaceutics”. International Journal of Life Science and Pharma Research, vol. 13, no. SP 1, Dec. 2022, pp. P55-P67, doi:10.22376/ijlpr.2023.13.SP1.P55-P67.